InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Monday, 12/05/2022 4:49:27 PM

Monday, December 05, 2022 4:49:27 PM

Post# of 367
MediWound Ltd. plans to enact a 1-for-7 reverse split of its ordinary shares.

Trading on a reverse split-adjusted basis is expected to begin on Dec. 20, the biopharmaceutical company said Monday.

MediWound, which is focused on next-generation biotherapeutic solutions for tissue repair and regeneration, had over 40.7 million ordinary shares outstanding as of Friday, according to FactSet.

Chief Executive Ofer Gonen said the reverse split is intended to increase shareholder value and attract new fundamental institutional investors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MDWD News